Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment

W Li, F Li, X Zhang, HK Lin, C Xu - Signal transduction and targeted …, 2021 - nature.com
More and more in-depth studies have revealed that the occurrence and development of
tumors depend on gene mutation and tumor heterogeneity. The most important …

Small-molecule MDM2 inhibitors in clinical trials for cancer therapy

S Wang, FE Chen - European journal of medicinal chemistry, 2022 - Elsevier
Disruption of the MDM2-p53 protein-protein interaction by small-molecule inhibitors has
been highly pursued by many academic laboratories and pharmaceutical companies as a …

FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application

S Wang, XH Yuan, SQ Wang, W Zhao, XB Chen… - European Journal of …, 2021 - Elsevier
Considerable progress has been made in the development of anticancer agents over the
past few decades, and a lot of new anticancer agents from natural and synthetic sources …

Triazole-fused pyrimidines in target-based anticancer drug discovery

XJ Dai, LP Xue, SK Ji, Y Zhou, Y Gao, YC Zheng… - European Journal of …, 2023 - Elsevier
In recent decades, the development of targeted drugs has featured prominently in the
treatment of cancer, which is among the major causes of mortality globally. Triazole-fused …

[HTML][HTML] Targeting cullin neddylation for cancer and fibrotic diseases

ZX He, W Yang, D Zengyangzong, G Gao, Q Zhang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Protein neddylation is a post-translational modification, and its best recognized substrates
are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs) …

Protein neddylation and its role in health and diseases

S Zhang, Q Yu, Z Li, Y Zhao, Y Sun - Signal Transduction and Targeted …, 2024 - nature.com
NEDD8 (Neural precursor cell expressed developmentally downregulated protein 8) is an
ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate …

NEDD8-conjugating enzyme E2s: critical targets for cancer therapy

L Zhou, X Lin, J Zhu, L Zhang, S Chen, H Yang… - Cell Death …, 2023 - nature.com
Abstract NEDD8-conjugating enzymes, E2s, include the well-studied ubiquitin-conjugating
enzyme E2 M (UBE2M) and the poorly characterized ubiquitin-conjugating enzyme E2 F …

Targeting neddylation E2s: a novel therapeutic strategy in cancer

YC Zheng, YJ Guo, B Wang, C Wang… - Journal of Hematology & …, 2021 - Springer
Ubiquitin-conjugating enzyme E2 M (UBE2M) and ubiquitin-conjugating enzyme E2 F
(UBE2F) are the two NEDD8-conjugating enzymes of the neddylation pathway that take part …

[HTML][HTML] Anticancer drug discovery by targeting cullin neddylation

Q Yu, Y Jiang, Y Sun - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Protein neddylation is a post-translational modification which transfers the ubiquitin-like
protein NEDD8 to a lysine residue of the target substrate through a three-step enzymatic …

Advances in cancer treatment by targeting the neddylation pathway

W Gai, Z Peng, CH Liu, L Zhang… - Frontiers in Cell and …, 2021 - frontiersin.org
Developmental down-regulation protein 8 (NEDD8), expressed by neural progenitors, is a
ubiquitin-like protein that conjugates to and regulates the biological function of its substrates …